Sylvie Ryckebusch
Corporate Officer/Principal at BIOINVENT INTERNATIONAL AB
Sylvie Ryckebusch active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BIOINVENT INTERNATIONAL AB | Corporate Officer/Principal | 08/06/2022 | - |
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Director/Board Member | - | - |
Career history of Sylvie Ryckebusch
Training of Sylvie Ryckebusch
| California Institute of Technology | Doctorate Degree |
| University of Maryland | Undergraduate Degree |
Statistics
International
| United States | 3 |
| France | 2 |
| Sweden | 2 |
Operational
| Director/Board Member | 1 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| BIOINVENT INTERNATIONAL AB | Health Technology |
| Private companies | 1 |
|---|---|
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Health Technology |
- Stock Market
- Insiders
- Sylvie Ryckebusch
- Experience
